The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).

Michael Kerin

The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).

Michael Kerin

Surgery

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Original language	English (Ireland)
Title of host publication	Annual Meeting of the American Society of Clinical Oncology
Place of Publication	USA
Publication status	Published - 1 Jun 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Walsh, EM,O'Loughlin, M,Shalaby, A,Webber, M,Kerin, MJ,Glynn, SA,Callagy, G,Keane, MM

Cite this

@inproceedings{a4da22de7df8438baea33454aa964091,

title = "The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).",

author = "Michael Kerin",

year = "2019",

month = jun,

day = "1",

language = "English (Ireland)",

booktitle = "Annual Meeting of the American Society of Clinical Oncology",

}

The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC). / Kerin, Michael.
Annual Meeting of the American Society of Clinical Oncology . USA, 2019.

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review